Correction to Merck to Buy OncoImmune Article
November 23 2020 - 08:37AM
Dow Jones News
OncoImmune reported positive results from a late-stage study of
a coronavirus therapeutic candidate. "Merck to Buy OncoImmune Amid
Covid-19 Vaccine Development," at 6:45 a.m. ET incorrectly said
that OncoImmune reported positive results from a late-stage study
of a coronavirus vaccine candidate.
(END) Dow Jones Newswires
November 23, 2020 08:22 ET (13:22 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2023 to Mar 2024